We are live on
!
Find out more
RS
R Squared Portfolio holdings
AUM
$182M
1-Year Est. Return
18.52%
This Fund
S&P 500
This Quarter
Est. Return
+0.01%
1 Year Est. Return
+18.52%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$103M
AUM Growth
–
Cap. Flow
+$107M
Cap. Flow
% of AUM
104.12%
Top 10 Holdings %
Top 10 Hldgs %
10.53%
Holding
1,571
New
1,571
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$2.59M |
| 2 |
FirstEnergy
FE
|
+$1.2M |
| 3 |
Eaton
ETN
|
+$1.08M |
| 4 |
Consolidated Edison
ED
|
+$1.06M |
| 5 |
Verizon
VZ
|
+$1M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.64% |
| 2 | Technology | 14.58% |
| 3 | Industrials | 13.88% |
| 4 | Consumer Discretionary | 12.94% |
| 5 | Healthcare | 11.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1076
BuzzFeed
BZFD
$95.7M
| $12.5K | 0.01% |
+4,680
| New | +$14.7K |
|
1077
Graham Corp
GHM
$1.25B
| $12.5K | 0.01% |
+280
| New | +$10.5K |
|
1078
Abbott
ABT
$176B
| $12.4K | 0.01% |
+110
| New | +$12.7K |
|
1079
AbbVie
ABBV
$455B
| $12.4K | 0.01% |
+70
| New | +$12.9K |
|
|
SCPH
1080
DELISTED
scPharmaceuticals
SCPH
| $12.4K | 0.01% |
+3,492
| New | +$13.4K |
|
1081
TTEC Holdings
TTEC
$94.4M
| $12.3K | 0.01% |
+2,470
| New | +$12.9K |
|
1082
Benchmark Electronics
BHE
$2.96B
| $12.3K | 0.01% |
+270
| New | +$12.5K |
|
1083
LG Display
LPL
$3.37B
| $12.2K | 0.01% |
+3,970
| New | +$14K |
|
1084
PepsiCo
PEP
$184B
| $12.2K | 0.01% |
+80
| New | +$13.1K |
|
1085
Sierra Bancorp
BSRR
$536M
| $12.1K | 0.01% |
+420
| New | +$12.6K |
|
1086
Harvard Bioscience
HBIO
$27.3M
| $12.1K | 0.01% |
+574
| New | +$13.2K |
|
1087
Rimini Street
RMNI
$395M
| $12.1K | 0.01% |
+4,520
| New | +$9.22K |
|
1088
German American Bancorp
GABC
$1.77B
| $12.1K | 0.01% |
+300
| New | +$12.7K |
|
1089
Methanex
MEOH
$4.49B
| $12K | 0.01% |
+240
| New | +$10.6K |
|
1090
C4 Therapeutics
CCCC
$401M
| $11.9K | 0.01% |
+3,310
| New | +$16.5K |
|
|
CRESY
1091
Cresud
CRESY
$806M
| $11.9K | 0.01% |
+948
| New | +$10.3K |
|
1092
Coupang
CPNG
$27.8B
| $11.9K | 0.01% |
+540
| New | +$13.3K |
|
1093
Beam Global
BEEM
$24.2M
| $11.9K | 0.01% |
+3,740
| New | +$15.4K |
|
1094
Denali Therapeutics
DNLI
$3.68B
| $11.8K | 0.01% |
+580
| New | +$14.8K |
|
1095
Ivanhoe Electric
IE
$1.41B
| $11.8K | 0.01% |
+1,560
| New | +$14.4K |
|
1096
Tejon Ranch
TRC
$479M
| $11.8K | 0.01% |
+740
| New | +$11.9K |
|
|
SNCR
1097
DELISTED
Synchronoss Technologies
SNCR
| $11.7K | 0.01% |
+1,220
| New | +$13K |
|
1098
Blue Bird Corp
BLBD
$2.51B
| $11.6K | 0.01% |
+300
| New | +$12.5K |
|
1099
iHeartMedia
IHRT
$538M
| $11.5K | 0.01% |
+5,820
| New | +$12.3K |
|
1100
Healthcare Services Group
HCSG
$1.55B
| $11.5K | 0.01% |
+990
| New | +$11.3K |
|
Similar funds
NED
CFG
CFG
WCM
TFP
AFS
EMB
TCPG
R Squared's Q4 2024 Portfolio in Review
Q4 2024 is the first quarter with a 13F filing on record for R Squared, which disclosed 1,571 positions worth $103M. Its ten largest holdings account for 11% of the portfolio.
Its largest position is Linde: 5,681 shares worth $2.38M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, followed by Technology and Industrials.
- R Squared's largest Q4 2024 buy was Linde: 5,681 shares worth $2.38M.
- R Squared's ten largest holdings make up 11% of its $103M portfolio in Q4 2024.
- R Squared disclosed 1,571 positions in Q4 2024, its first 13F filing on record.
Based on R Squared's 13F filing for Q4 2024, filed 23 Jan 2025.